Cancer Pain Mechanisms and Etiology

  • Richard Payne
Part of the Current Management of Pain book series (CUMP, volume 3)


Pain associated with cancer may result from tumor infiltration of pain-sensitive structures, injury to nerves, bone, and soft tissue as a result of chemotherapy, radiotherapy, or surgery, and tumor or radiation-induced vascular occlusion (table 1–1) [8,15]. One can distinguish three basic categories or types of pain: somatic, visceral and deafferentation (table 1–2).


Cancer Pain Tumor Infiltration Visceral Pain Opiate Receptor Pain Research 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Albe-Fessard D, Lombard MC (1983): Use of an animal model to evaluate the origin of and protection against deafferentation pain. In: Bonica JJ et al. (eds), Advances in Pain Research and Therapy, vol 5. New York: Raven Press, pp 691–700.Google Scholar
  2. 2.
    Albe-Fessard D, Condes-Lara M, Sanderson P, et al. (1984): Tentative explanation of the special role played by the areas of paleospinothalamic projection in patients with deafferentation pain syndromes. In: Kruger L, Liebskind JC (eds), Neural Mechanisms of Pain (Advances in Pain Research and Therapy, vol 6 ). New York: Raven Press, pp 167–182.Google Scholar
  3. 3.
    Asbury AK, Fields HL (1984): Pain due to peripheral nerve damage: An hypothesis. Neurology 34: 1587–1590.PubMedGoogle Scholar
  4. 4.
    Atweh SF, Kuhar MJ (1977): Autoradiographic localization of opiate receptors in the rat brain. I. Spinal Cord and Lower Medulla. Brain Res 124: 53–67.PubMedCrossRefGoogle Scholar
  5. 5.
    Basbaum AI, Fields HF (1978): Endogenous pain control mechanisms: Review and hypothesis. Ann Neurol 4: 451–462.PubMedCrossRefGoogle Scholar
  6. 6.
    Basbaum AI (1983): The generation and control of pain. In: Rosenberg RN (ed), The Clinical Neurosciences, vol 5. New York: Churchill Livingstone, pp 301–324.Google Scholar
  7. 7.
    Bonica JJ (1953): The Management of Pain. Philadelphia: Lea and Febiger, p 48.Google Scholar
  8. 8.
    Bonica JJ (1985): Treatment of cancer pain: Current status and future needs. In: Fields HL, Dubner R, Cervero F (eds), Advances in Pain Research and Therapy, vol 9. New York: Raven Press, pp 589–616.Google Scholar
  9. 9.
    Brodie GN (1974): Indomethacin and bone pain. Lancet i: 1160.Google Scholar
  10. 10.
    Culp WJ, Ochoa J (1982): Abnormal Nerves and Muscles as Impulse Generators. New York: Oxford University Press.Google Scholar
  11. 11.
    Devor M (1983): Nerve pathophysiology and mechanisms of pain in causalgia. J Auton Nery Syst, 7: 371–384.CrossRefGoogle Scholar
  12. 12.
    Duggan AW, North RA (1983): Electrophysiology of opioids. Pharmacol Rev, 35: 219–282.PubMedGoogle Scholar
  13. 13.
    Ferreira SH, Nakamura M, Castro MSA (1978): The hyperalgesic effects of prostacyclin and prostaglandin E2. Prostaglandins 16: 31–37.PubMedCrossRefGoogle Scholar
  14. 14.
    Foley KM (1981): Analgesic management of bone pain. In: Weiss L, Gilbert HA (eds), Bone Metastasis. Boston: G.K. Hall Medical Publishers, pp 348–368.Google Scholar
  15. 15.
    Foley KM (1985): The treatment of cancer pain. N Engl J Med 313: 84–95.PubMedCrossRefGoogle Scholar
  16. 16.
    Fredrickson RCA (1984): Endogenous opioids and related derivatives. In: Kuhar M, Pasternak G (eds), Analgesics: Neurochemical, Behavioral and Clinical Perspectives. New York: Raven Press, pp 9–68.Google Scholar
  17. 17.
    Galasko CSB (1976): Mechanism of bone destruction in the development of skeletal metastasis. Nature 263: 507–510.PubMedCrossRefGoogle Scholar
  18. 18.
    Ghostine SY, Comair YG, Turner DM, et al. (1984): Phenoxybenzamine in the treatment of causalgia. J Neurosurg 60: 1263–1268.PubMedCrossRefGoogle Scholar
  19. 19.
    Gracely RH, McGrath P, Dubner T (1979): Narcotic analgesia: Fentanyl reduces the intensity but not the unpleasantness of painful tooth pulp sensations. Science 203: 1261–1263.PubMedCrossRefGoogle Scholar
  20. 20.
    Hagbarth K-E (1979): Exteroceptive, proprioceptive, and sympathetic activity recorded with microelectrodes from human peripheral nerves. Mayo Clin Proc 54: 353–365.PubMedGoogle Scholar
  21. 21.
    Hagbarth K-E, Torebjork HE, Wallin BG (1984): Microelectrode recordings from human skin and muscle nerves. In: Dyck PJ, Thomas PK, Lambert EH et al., Peripheral Neuropathy, vol 1, 2nd edition. Philadelphia: W.B. Saunders Co., pp 1016–1029.Google Scholar
  22. 22.
    Head H (1893): On disturbances of sensation with especial reference to pain of visceral disease. Brain 16: 1–132.CrossRefGoogle Scholar
  23. 23.
    Iwamoto ET, Martin WR (1981): Multiple opiate receptors. Med Res Rev 1: 411–440.PubMedCrossRefGoogle Scholar
  24. 24.
    Jaeckle KA, Young DF, Foley KM (1985): The natural history of lumbosacral plexopathy in cancer. Neurology 35: 8–15.PubMedGoogle Scholar
  25. 25.
    Kori SH, Foley KM, Posner JB (1981): Brachial plexus lesions in patients with cancer: 100 cases. Neurology 31: 45–50.PubMedGoogle Scholar
  26. 26.
    LaMotte RH, Campbell JN (1978): Comparison of responses of warm and nociceptor afferents in monkey with human judgements of thermal pain. J Neurophysiol 41: 509–528.PubMedGoogle Scholar
  27. 27.
    Lasagna L, van Felsinger JM, Beecher HK (1955): Drug-induced mood changes in man. I. Observations on healthy subjects, chronically ill patients and “postaddicts. ” JAMA 157: 1006–1020.Google Scholar
  28. 28.
    Learmouth JR (1931): A contribution to the neurophysiology of the urinary bladder in man. Brain 54: 147–176.CrossRefGoogle Scholar
  29. 29.
    Leek BF (1972): Abdominal visceral receptors. In: Neil (ed), Handbook of Sensory Physiology, vol 13. Berlin: Springer, pp 113–160.Google Scholar
  30. 30.
    Ling GSF, Pasternak GW (1983): Spinal and supraspinal analgesia in the mouse: The role of opioid binding sites. Brain Res 271: 152–156.PubMedCrossRefGoogle Scholar
  31. 31.
    Ling GSF, Macleod JM, Lee S, et al. (1984): Separation of morphine analgesia from physical dependence. Science 226: 462–464.PubMedCrossRefGoogle Scholar
  32. 32.
    Ling GSF, Spiegel K, Lockhart SH, et al. (1985): Separation of opioid analgesia from respiratory depression: Evidence for different receptor mechanisms. J Pharmacol Exp Ther 232: 149–151.PubMedGoogle Scholar
  33. 33.
    Loh L, Nathan PW (1978): Painful peripheral states and sympathetic blocks. J Neurol Neurosurg Psych 41: 664–671.CrossRefGoogle Scholar
  34. 34.
    Maciewicz R, Bouckoms A, Martin JB (1985): Drug therapy for neuropathie pain. The Clinical Journal of Pain 1: 39–49.CrossRefGoogle Scholar
  35. 35.
    McLellan AM, Goddell H (1943): Pain from the bladder, ureter, and kidney pelvis. Res Publ Assoc Res Nery Ment Disease 23: 252–262.Google Scholar
  36. 36.
    Meyer RA, Campbell JN (1981): Myelinated nociceptive afferent account for the hyperalgesia that follows a burn to the hand. Science 213: 1527–1529.PubMedCrossRefGoogle Scholar
  37. 37.
    Milne RJ, Foreman RD, Giesler GJ, et al. (1981): Convergence of cutaneous and pelvic visceral nociceptive inputs onto primate spinothalamic neurons. Pain 11: 163–181.PubMedCrossRefGoogle Scholar
  38. 38.
    Moulin DE, Max MB, Kaiko RF, et al. (1985): The analgesic efficacy of intrathecal d-ala2-d-leu5enkephalin in cancer patients with chronic pain. Pain 23: 213–221.PubMedCrossRefGoogle Scholar
  39. 39.
    Nathan PW (1983): Pain and the sympathetic nervous system. J Auton Nery Syst 7: 363–370.CrossRefGoogle Scholar
  40. 40.
    Newman PP (1974): Visceral Afferent Functions of the Nervous System. London: Arnold.Google Scholar
  41. 41.
    Ochoa JL, Torebjork E, Marchettini P, et al. (1985): Mechanisms of neuropathie pain: Cumulative observation, new experiments and further speculation. In: Fields HL, Dubner R, Cervero F (eds), Advances in Pain Research and Therapy, vol 9. New York: Raven Press, pp 431–450.Google Scholar
  42. 42.
    Pasternak GW (1986): Multiple mu opiate receptors: Biochemical and pharmacological evidence for multiplicity. Biochem Pharmacol, 35: 361–364.PubMedCrossRefGoogle Scholar
  43. 43.
    Perl ER (1984): Characterization of nociceptors and their activation of neurons in the superficial dorsal horn: First steps for the sensation of pain. In: Kruger L, Liebeskind JC (eds), Neural Mechanisms of Pain (Advances in Pain Research and Therapy, vol 6 ). New York: Raven Press, pp 23–52.Google Scholar
  44. 44.
    Pleet AB, Tahmans AJ, Jennings JR (1976): Causalgia treatment with propranolol. Neurology 26: 375.Google Scholar
  45. 45.
    Powles TJ, Clark SA, Easty DM, et al. (1973): The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcemia in rats with Walker tumor and its possible application to human breast cancer. Br J Cancer 28: 316–321.PubMedCrossRefGoogle Scholar
  46. 46.
    Price DD, der Gruen AV, Miller J, et al. (1985): A psychophysical analysis of morphine analgesia. Pain 29: 961–269.Google Scholar
  47. 47.
    Roberts WJ, Elardo SM (1985): Sympathetic activation of A-delta nociceptors. Somatosens 3: 33–44.CrossRefGoogle Scholar
  48. 48.
    Ruch TC (1946): Visceral sensation and referred pain. In: Fulton (ed): Howell’s Textbook of Physiology, 15th edition. Philadelphia: Saunders, pp 385–401.Google Scholar
  49. 49.
    Sinclair DC, Weddel G, Feindel WH (1948): Referred pain and associated phenomena. Brain 71: 184–211.PubMedCrossRefGoogle Scholar
  50. 50.
    Smith GM, Beecher HK (1962): Objective evidence of mental effects of heroin, morphine and placebo in normal subjects. J Pharmacol Exp Ther 136: 53–58.PubMedGoogle Scholar
  51. 51.
    Snyder SH (1977): Opiate receptors in the brain. N Engl J Med, 296: 266–271.PubMedCrossRefGoogle Scholar
  52. 52.
    Spiegel K, Pasternak GW (1984): Meptazinol: A novel mu-1 selective opioid analgesic. J Pharm Exp Ther 228: 414–419.Google Scholar
  53. 53.
    Stoll BA (1973): Indomethacin and breast cancer. Lancet i: 384.Google Scholar
  54. 54.
    Swerdlow M (1984): Anticonvulsant drugs and chronic pain. Clin Neuropharmacol 7: 51–82.PubMedCrossRefGoogle Scholar
  55. 55.
    Tasker RR, Tsuda T, Hawrylyshyn (1983): Clinical neurophysiological investigation of deafferentation pain. In: Bonica JJ (ed), Advances in Pain Research and Therapy, vol 5. New York: Raven Press, pp 713–738.Google Scholar
  56. 56.
    Tasker RR (1984): Deafferentation. In: Wall PD, Melzack R (eds), Textbook of Pain. New York: Churchill Livingstone, pp 119–132.Google Scholar
  57. 57.
    Torebjork HE (1979): Activity in C nociceptors and sensation. In: Kenshalo DR (ed): Sensory Function of the Skin of Humans. New York: Plenum Press, pp 313–325.Google Scholar
  58. 58.
    Torebjork HE, Hallin RG (1979): Microneurographic studies of peripheral pain mechanisms in man. In: Bonica JJ (ed), Advances in Pain Research and Therapy, vol 3. New York: Raven Press, pp 121–131.Google Scholar
  59. 59.
    Vallbo AB, Hagbarth K-E, Torebjork HE, et al. (1979): Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 59: 919–957.PubMedGoogle Scholar
  60. 60.
    van Hees J, Gybels JM (1972): Pain related to single afferent C-fibers from human skin. Brain Res 48: 397–400.PubMedCrossRefGoogle Scholar
  61. 61.
    Walker AE, Nulson F (1948): Electrical stimulation of the upper thoracic portion of the sympathetic chain in man. Arch Neurol Psych 5: 559–560.Google Scholar
  62. 62.
    Wall PD, McMahon SB (1985): Microneuronography and its relation to perceived sensation. A critical review. Pain 21: 209–229.PubMedCrossRefGoogle Scholar
  63. 63.
    Wall PD (1985): Cancer pain: Neurogenic mechanisms. In: Fields HL, Dubner R, Cervero F (eds), Advances in Pain Research and Therapy, vol 9. New York: Raven Press, pp 575–587.Google Scholar
  64. 64.
    Wang JK, Nauss LA, Thomas JE (1979): Pain relief by intrathecally-applied morphine in man. Anesthesiology 50: 149–151.PubMedCrossRefGoogle Scholar
  65. 65.
    Willis WD (1985): The Pain System: The Neural Basis of Nociceptive Transmission in the Mammalian Nervous System. Basel: S. Karger.Google Scholar
  66. 66.
    Yaksh TL (1981): Spinal opiate analgesia: Characteristics and principles of action. Pain 11: 293–347.PubMedCrossRefGoogle Scholar
  67. 67.
    Yaksh TL, Hammond DL (1982): Peripheral and central substrates involved in the rostrad transmission of nociceptive information. Pain 13: 1–85.PubMedCrossRefGoogle Scholar
  68. 68.
    Yaksh TL (1983): In vivo studies on spinal opiate receptor systems mediating antinociception. I. mu and delta receptor profiles in the primate. J Pharmacol Exp Ther 226: 303–316.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers, Boston 1989

Authors and Affiliations

  • Richard Payne

There are no affiliations available

Personalised recommendations